Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $52,971 | 102 | 29.1% |
| Consulting Fee | $40,966 | 12 | 22.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,231 | 14 | 21.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $29,500 | 14 | 16.2% |
| Honoraria | $10,350 | 4 | 5.7% |
| Food and Beverage | $5,030 | 73 | 2.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,000 | 3 | 2.2% |
| Gift | $21.79 | 3 | 0.0% |
| Education | $20.04 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $113,719 | 147 | $0 (2024) |
| Alcresta Therapeutics, Inc. | $50,690 | 50 | $0 (2024) |
| TETRAPHASE PHARMACEUTICALS, INC. | $8,452 | 4 | $0 (2019) |
| Grifols Shared Services North America, Inc. | $4,788 | 7 | $0 (2019) |
| Covidien LP | $2,780 | 8 | $0 (2019) |
| Becton, Dickinson and Company | $1,042 | 2 | $0 (2022) |
| Boston Scientific Corporation | $234.56 | 2 | $0 (2024) |
| Orthofix Medical, Inc. | $122.48 | 1 | $0 (2018) |
| TELA Bio, Inc. | $107.72 | 1 | $0 (2024) |
| CSL Behring | $105.21 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,869 | 86 | Fresenius Kabi USA, LLC ($42,058) |
| 2023 | $24,257 | 49 | Fresenius Kabi USA, LLC ($16,145) |
| 2022 | $15,105 | 22 | Fresenius Kabi USA, LLC ($11,136) |
| 2021 | $5,831 | 3 | Fresenius Kabi USA, LLC ($5,081) |
| 2020 | $26,901 | 25 | ALCRESTA THERAPEUTICS, INC. ($21,916) |
| 2019 | $40,387 | 32 | Fresenius Kabi USA, LLC ($13,696) |
| 2018 | $23,634 | 9 | Fresenius Kabi USA, LLC ($21,154) |
| 2017 | $105.21 | 1 | CSL Behring ($105.21) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $547.42 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $273.40 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $223.43 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $64.00 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $59.15 | General |
| Category: Parental Nutrition | ||||||
| 11/13/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $17.60 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $513.50 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $220.93 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $132.83 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $96.00 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $51.51 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $51.48 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $37.20 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $34.79 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $27.51 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Parental Nutrition | ||||||
| 10/30/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $8.67 | General |
| Category: Parental Nutrition | ||||||
| 10/29/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Parental Nutrition | ||||||
| 10/29/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $513.50 | General |
| Category: Parental Nutrition | ||||||
| 10/29/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Travel and Lodging | In-kind items and services | $220.93 | General |
| Category: Parental Nutrition | ||||||
| 10/29/2024 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $133.00 | General |
| Category: Parental Nutrition | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 246 | 334 | $91,403 | $34,679 |
| 2022 | 7 | 310 | 393 | $103,665 | $39,426 |
| 2021 | 7 | 270 | 340 | $85,081 | $32,166 |
| 2020 | 7 | 271 | 342 | $79,417 | $31,962 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 102 | $41,106 | $16,978 | 41.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 53 | $11,342 | $4,831 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 72 | $13,176 | $4,215 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $13,283 | $4,022 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $7,105 | $2,767 | 38.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 26 | $3,276 | $980.50 | 29.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $2,115 | $885.64 | 41.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 58 | 97 | $39,091 | $16,523 | 42.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 51 | $18,309 | $7,580 | 41.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 85 | $18,190 | $6,491 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 90 | $16,470 | $4,946 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $4,900 | $1,825 | 37.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 27 | 27 | $3,807 | $1,385 | 36.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 22 | 23 | $2,898 | $675.81 | 23.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 35 | 59 | $23,777 | $9,862 | 41.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 109 | $23,326 | $8,650 | 37.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $16,155 | $6,310 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 53 | $9,699 | $3,007 | 31.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $4,900 | $2,075 | 42.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 27 | 28 | $3,948 | $1,486 | 37.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 26 | $3,276 | $776.47 | 23.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 33 | 64 | $25,792 | $11,272 | 43.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 55 | 72 | $14,988 | $5,762 | 38.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 82 | $13,356 | $4,434 | 33.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 27 | 27 | $9,693 | $4,301 | 44.4% |
About Dr. David Evans, M.D
Dr. David Evans, M.D is a Surgical Critical Care healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851517031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Evans, M.D has received a total of $182,088 in payments from pharmaceutical and medical device companies, with $45,869 received in 2024. These payments were reported across 227 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($52,971).
As a Medicare-enrolled provider, Evans has provided services to 1,097 Medicare beneficiaries, totaling 1,409 services with total Medicare billing of $138,232. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Surgical Critical Care
- Other Specialties Trauma Surgery
- Location Columbus, OH
- Active Since 04/17/2007
- Last Updated 01/25/2022
- Taxonomy Code 2086S0102X
- Entity Type Individual
- NPI Number 1851517031
Products in Payments
- Smoflipid (Drug) $70,753
- RELIZORB (Device) $50,690
- MD-Other (Drug) $13,696
- Xerava (Drug) $8,452
- Thrombate III (Biological) $4,788
- OMEGAVEN (Drug) $1,260
- SpyGlass Discover (Device) $234.56
- All Spine Stimulation (Biological) $122.48
- OviTex 2S (Device) $107.72
- Kcentra (Biological) $105.21
- BRIDION (Drug) $18.09
- ANDEXXA (Biological) $16.32
- ER-REBOA (Device) $10.67
- ZERBAXA (Drug) $1.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Critical Care Doctors in Columbus
Nicole Bernal, Md, MD
Surgical Critical Care — Payments: $27,151
Dr. Carrie Valdez, Md, MD
Surgical Critical Care — Payments: $26,856
Lois Sakorafas, M.d, M.D
Surgical Critical Care — Payments: $12,732
Erich Wessel, D.o, D.O
Surgical Critical Care — Payments: $10,725
Andrew Young, Md, MD
Surgical Critical Care — Payments: $10,110
Dr. Brian Dusseau, Do, DO
Surgical Critical Care — Payments: $4,269